These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1462831)

  • 21. Partial purification and characterization of contact activation cofactor.
    Schiffman S; Lee P
    J Clin Invest; 1975 Nov; 56(5):1082-92. PubMed ID: 1184736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.
    Sinha D; Seaman FS; Koshy A; Knight LC; Walsh PN
    J Clin Invest; 1984 Jun; 73(6):1550-6. PubMed ID: 6609936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface adsorption of factor XI. II. Evidence that different mechanisms are involved in binding to glass and plastic materials.
    Mannhalter C; Schiffman S
    Thromb Haemost; 1982 Jun; 47(3):214-7. PubMed ID: 6981227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The possible role of platelets in bypassing the contact phase of blood coagulation.
    Walsh PN; Tuszynski GP; Greengard JS; Griffin JH
    Haematologia (Budap); 1984; 17(2):169-78. PubMed ID: 6534825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on factor XII in porcine plasma: purification and its conversion to activated form by porcine plasma kallikrein.
    Mashiko H; Kato K; Fujii K; Takahashi H
    Biochim Biophys Acta; 1996 Sep; 1296(2):198-206. PubMed ID: 8814227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dedicated removal of immunoglobulin (Ig)A, IgM, and Factor (F)XI/activated FXI from human plasma IgG.
    Wu YW; Champagne J; Toueille M; Gantier R; Burnouf T
    Transfusion; 2014 Jan; 54(1):169-78. PubMed ID: 23701287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a defective factor XI cross-reacting material in a factor XI-deficient patient.
    Mannhalter C; Hellstern P; Deutsch E
    Blood; 1987 Jul; 70(1):31-7. PubMed ID: 2439152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contact activation of factor XI.
    Jacobs A; Mannhalter C; Margalit R; Schiffman S
    Br J Haematol; 1981 Sep; 49(1):77-86. PubMed ID: 7272231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine monoclonal antibodies to human factor XI.
    Nishikado H; Komiyama Y; Masuda M; Egawa H; Murata K
    Thromb Res; 1986 Apr; 42(2):225-34. PubMed ID: 3487138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of coagulation factor XI by a casein kinase released by activated human platelets increases its susceptibility to activation by factor XIIa and thrombin.
    Ekdahl KN; Elgue G; Nilsson B
    Thromb Haemost; 1999 Oct; 82(4):1283-8. PubMed ID: 10544914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor IX activation by factor XIa proceeds without release of a free intermediate.
    Wolberg AS; Morris DP; Stafford DW
    Biochemistry; 1997 Apr; 36(14):4074-9. PubMed ID: 9100000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and characterization of platelet factor XI.
    Schiffman S; Yeh CH
    Thromb Res; 1990 Oct; 60(1):87-97. PubMed ID: 2278039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular cloning and biochemical characterization of rabbit factor XI.
    Sinha D; Marcinkiewicz M; Gailani D; Walsh PN
    Biochem J; 2002 Oct; 367(Pt 1):49-56. PubMed ID: 12084014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and functional properties of factor XI and prekallikrein.
    Mannhalter CH
    Semin Thromb Hemost; 1987 Jan; 13(1):25-35. PubMed ID: 3551075
    [No Abstract]   [Full Text] [Related]  

  • 35. A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.
    Miller TN; Sinha D; Baird TR; Walsh PN
    Biochemistry; 2007 Dec; 46(50):14450-60. PubMed ID: 18020374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of charged groups in factor XI/XIa activity.
    Morgan K; Schiffman S
    J Biol Chem; 1982 Oct; 257(19):11284-7. PubMed ID: 6981645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of factor IX BM. Difference of cleavage sites by factor XIa and Ca2+ in factor IX Kashihara, factor IX Nagoya and factor IX Niigata.
    Yoshioka A; Ohkubo Y; Nishimura T; Tanaka I; Fukui H; Ogata K; Kamiya T; Takahashi H
    Thromb Res; 1986 Jun; 42(5):595-604. PubMed ID: 3487139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperative Ca2+ binding to human factor IX. Effects of Ca2+ on the kinetic parameters of the activation of factor IX by factor XIa.
    Bajaj SP
    J Biol Chem; 1982 Apr; 257(8):4127-32. PubMed ID: 6978337
    [No Abstract]   [Full Text] [Related]  

  • 39. Purification and characterization of hepatocyte growth factor (HGF)-converting enzyme: activation of pro-HGF.
    Mizuno K; Tanoue Y; Okano I; Harano T; Takada K; Nakamura T
    Biochem Biophys Res Commun; 1994 Feb; 198(3):1161-9. PubMed ID: 8117273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Purification of factor XIa inhibitor from human platelets.
    Komiyama Y; Murakami T; Egawa H; Okubo S; Yasunaga K; Murata K
    Thromb Res; 1992 May; 66(4):397-408. PubMed ID: 1412206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.